237 related articles for article (PubMed ID: 31387920)
1. The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.
Park DS; Robertson-Tessi M; Luddy KA; Maini PK; Bonsall MB; Gatenby RA; Anderson ARA
Cancer Res; 2019 Oct; 79(20):5302-5315. PubMed ID: 31387920
[TBL] [Abstract][Full Text] [Related]
2. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
Büll C; Boltje TJ; Balneger N; Weischer SM; Wassink M; van Gemst JJ; Bloemendal VR; Boon L; van der Vlag J; Heise T; den Brok MH; Adema GJ
Cancer Res; 2018 Jul; 78(13):3574-3588. PubMed ID: 29703719
[TBL] [Abstract][Full Text] [Related]
3. Immunoengineering through cancer vaccines - A personalized and multi-step vaccine approach towards precise cancer immunity.
Lybaert L; Vermaelen K; De Geest BG; Nuhn L
J Control Release; 2018 Nov; 289():125-145. PubMed ID: 30223044
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
Yu WD; Sun G; Li J; Xu J; Wang X
Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
[TBL] [Abstract][Full Text] [Related]
5. Metronomic chemotherapy and immunotherapy in cancer treatment.
Chen YL; Chang MC; Cheng WF
Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors: The linchpins of modern immunotherapy.
Wilky BA
Immunol Rev; 2019 Jul; 290(1):6-23. PubMed ID: 31355494
[TBL] [Abstract][Full Text] [Related]
7. [Immune system and tumors].
Terme M; Tanchot C
Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
[TBL] [Abstract][Full Text] [Related]
8. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
Emens LA; Jaffee EM
Cancer Res; 2005 Sep; 65(18):8059-64. PubMed ID: 16166275
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery for Cancer Immunotherapy and Vaccines.
Batty CJ; Tiet P; Bachelder EM; Ainslie KM
Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
[TBL] [Abstract][Full Text] [Related]
10. Immunological aspects of cancer chemotherapy.
Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
[TBL] [Abstract][Full Text] [Related]
11. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
12. How to improve the immunogenicity of chemotherapy and radiotherapy.
Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L
Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323
[TBL] [Abstract][Full Text] [Related]
13. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
14. Targeting Resident Memory T Cells for Cancer Immunotherapy.
Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E
Front Immunol; 2018; 9():1722. PubMed ID: 30100906
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
Wu J; Waxman DJ
Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
[TBL] [Abstract][Full Text] [Related]
17. [Benefits of combining chemotherapy with immuno- oncology therapies or "Is it true that chemotherapy destroys the immune system?"].
Kocsis J
Magy Onkol; 2019 Sep; 63(3):202-207. PubMed ID: 31533140
[TBL] [Abstract][Full Text] [Related]
18. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Varn FS; Schaafsma E; Wang Y; Cheng C
Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
[TBL] [Abstract][Full Text] [Related]
19. Injecting Hope--A Review of Breast Cancer Vaccines.
Mittendorf EA; Peoples GE
Oncology (Williston Park); 2016 May; 30(5):475-81, 485. PubMed ID: 27188680
[TBL] [Abstract][Full Text] [Related]
20. NK cells and Immunotherapy.
Tian Z
Semin Immunol; 2017 Jun; 31():1-2. PubMed ID: 28985906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
